Literature DB >> 17655940

MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum.

Stefanie Kuerten1, Dilyana A Kostova-Bales, Lukas P Frenzel, Justine T Tigno, Magdalena Tary-Lehmann, Doychin N Angelov, Paul V Lehmann.   

Abstract

Mechanism-oriented studies of EAE rely mostly on gene-modified mice on the C57BL/6 background. Here we report that MP4-induced EAE displays characteristic differences in CNS pathology as compared to MOG peptide 35-55-elicited disease. While in the latter, the topology of CNS infiltration remained unchanged throughout the disease, in MP4-induced EAE it was dynamic and stage-dependent shifting from the brain to the spinal cord and finally to the cerebellum. Unlike in the MOG peptide model, the frequencies and sizes of CNS lesions in MP4-induced disease showed a clear correlation with clinical disease severity. These characteristic features of MP4-induced EAE may contribute to modelling the complex spectrum of disease manifestations seen in MS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17655940      PMCID: PMC2083209          DOI: 10.1016/j.jneuroim.2007.06.016

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  45 in total

1.  Regression and spreading of self-recognition during the development of autoimmune demyelinating disease.

Authors:  V K Tuohy; M Yu; L Yin; J A Kawczak; P R Kinkel
Journal:  J Autoimmun       Date:  1999-08       Impact factor: 7.094

2.  Demyelination in the guinea pig in chronic allergic encephalomyelitis produced by injecting guinea pig brain in oil emulsion containing a variant of mycobacterium butyricum.

Authors:  J FREUND; M M LIPTON; L R MORRISON
Journal:  Arch Pathol (Chic)       Date:  1950-07

3.  Experimental studies on acute disseminated encephalomyelitis in rhesus monkeys.

Authors:  E A KABAT; A WOLF; A E BEZER
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1950

Review 4.  Rodent models of experimental allergic encephalomyelitis applied to the study of multiple sclerosis.

Authors:  J Goverman; T Brabb
Journal:  Lab Anim Sci       Date:  1996-10

5.  Active and passive experimental autoimmune encephalomyelitis in strain 129/J (H-2b) mice.

Authors:  R B Fritz; M L Zhao
Journal:  J Neurosci Res       Date:  1996-08-15       Impact factor: 4.164

Review 6.  Axonal pathology in multiple sclerosis: relationship to neurologic disability.

Authors:  B D Trapp; R Ransohoff; R Rudick
Journal:  Curr Opin Neurol       Date:  1999-06       Impact factor: 5.710

Review 7.  Candidate autoantigens in multiple sclerosis.

Authors:  S Schmidt
Journal:  Mult Scler       Date:  1999-06       Impact factor: 6.312

8.  Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.

Authors:  T Berger; S Weerth; K Kojima; C Linington; H Wekerle; H Lassmann
Journal:  Lab Invest       Date:  1997-03       Impact factor: 5.662

9.  Spreading of the immune response to different myelin basic protein peptides in chronic experimental autoimmune encephalomyelitis in B10.RIII mice.

Authors:  L Jansson; P Diener; A Engström; T Olsson; R Holmdahl
Journal:  Eur J Immunol       Date:  1995-08       Impact factor: 5.532

10.  A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.

Authors:  M Yu; J M Johnson; V K Tuohy
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  34 in total

1.  Decreased levels of constitutive proteasomes in experimental autoimmune encephalomyelitis may be caused by a combination of subunit displacement and reduced Nfe2l1 expression.

Authors:  Kara L Shanley; Che-Lin Hu; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2019-12-02       Impact factor: 5.372

2.  Neuroprotection by ulinastatin in experimental autoimmune encephalomyelitis.

Authors:  Yaqing Shu; Yu Yang; Wei Qiu; Zhengqi Lu; Ying Li; Jian Bao; Ming Feng; Xueqiang Hu
Journal:  Neurochem Res       Date:  2011-06-12       Impact factor: 3.996

Review 3.  The development of myelin repair agents for treatment of multiple sclerosis: progress and challenges.

Authors:  Robert P Murphy; Keith J Murphy; Mark Pickering
Journal:  Bioengineered       Date:  2012-11-12       Impact factor: 3.269

4.  The role of chromogranin B in an animal model of multiple sclerosis.

Authors:  Michelle Mo; Ha Thi Hoang; Stefan Schmidt; Robert B Clark; Barbara E Ehrlich
Journal:  Mol Cell Neurosci       Date:  2013-04-24       Impact factor: 4.314

5.  Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4.

Authors:  Saisha A Nalawade; Niannian Ji; Itay Raphael; Andrew Pratt; Ellen Kraig; Thomas G Forsthuber
Journal:  Cell Immunol       Date:  2018-05-14       Impact factor: 4.868

6.  Accumulation of protein carbonyls within cerebellar astrocytes in murine experimental autoimmune encephalomyelitis.

Authors:  Jianzheng Zheng; Oscar A Bizzozero
Journal:  J Neurosci Res       Date:  2010-11-15       Impact factor: 4.164

7.  Differential Expression of Klotho in the Brain and Spinal Cord is Associated with Total Antioxidant Capacity in Mice with Experimental Autoimmune Encephalomyelitis.

Authors:  Mohammad Sajad Emami Aleagha; Mohammad Hossein Harirchian; Shahram Lavasani; Mohammad Javan; Abdolamir Allameh
Journal:  J Mol Neurosci       Date:  2018-03-14       Impact factor: 3.444

8.  Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis.

Authors:  Itzy E Morales Pantoja; Che-Lin Hu; Nora I Perrone-Bizzozero; Jianzheng Zheng; Oscar A Bizzozero
Journal:  J Neurochem       Date:  2016-09-19       Impact factor: 5.372

9.  Berberine attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.

Authors:  Xiaomeng Ma; Ying Jiang; Aimin Wu; Xiaohong Chen; Rongbiao Pi; Mei Liu; Yingying Liu
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

10.  Novel therapeutic approach by nicotine in experimental model of multiple sclerosis.

Authors:  Fatemeh Naddafi; Mohsen Reza Haidari; Gholamreza Azizi; Reza Sedaghat; Abbas Mirshafiey
Journal:  Innov Clin Neurosci       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.